400 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Curis Competitors or Alternatives

Curis's top competitors include Emmaus, Kurome Therapeutics and Kymera.

Unlock 26 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Curis's company profile

James E. Dentzer

President & CEO

96/100
60
$121.3M
$10.9M
  • $121.3M
    $10.9M
  • 60
    $121.3M
  • $10.9M
  • 96/100
  • 60
  • $121.3M
  • $10.9M
View ProfileView
1
Curis's Competitor - Emmaus logo

Willis C. Lee

CEO

82/100
55
$118.7M
$20.4M
  • $118.7M
    $20.4M
  • 55
    $118.7M
  • $20.4M
  • 82/100
  • 55
  • $118.7M
  • $20.4M
View ProfileView
2
Curis's Competitor - Kurome Therapeutics logo

Jan Rosenbaum

President & CEO

90/100
1 - 25
$15M
$100K - 5M
  • $15M
    $100K - 5M
  • 1 - 25
    $15M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $15M
  • $100K - 5M
View ProfileView
3
Curis's Competitor - Kymera logo

Nello Mainolfi

President & CEO

88/100
170
$1.1B
$47.1M
  • $1.1B
    $47.1M
  • 170
    $1.1B
  • $47.1M
  • 88/100
  • 170
  • $1.1B
  • $47.1M
View ProfileView
4
Curis's Competitor - Apexigen logo

Xiaodong Yang

President & CEO

90/100
1 - 25
$160.8M
  • $160.8M
  • 1 - 25
    $160.8M
  • 90/100
  • 1 - 25
  • $160.8M
View ProfileView
5
Curis's Competitor - Kineta logo

Craig W. Philips

President

82/100
4
$139.1M
$5.4M
  • $139.1M
    $5.4M
  • 4
    $139.1M
  • $5.4M
  • 82/100
  • 4
  • $139.1M
  • $5.4M
View ProfileView
Curis' top 29 competitors are Emmaus, Kurome Therapeutics, Kymera, Rigel Pharmaceuticals, Apexigen, Kineta, PharmAbcine, Sensei Bio, Regeneron, Incyte, Novartis, Bristol-Myers Squibb, Lilly, Merck, Hummingbird Bioscience, PTC, Pharmacyclics, Evotec, ZYDELIG, Inotek Pharmaceuticals, Orexigen Therapeutics, Inc., Centrose, Polaris, Takeda Pharmaceutical, Nanobiotix, Diffusion Pharmaceuticals, NeurogesX, Aeglea and CR Pharmaceutical. Together they have raised over 45.5B between their estimated 363.6K employees. Curis has 60 employees and is ranked 19th among it's top 10 competitors. The top 10 competitors average 12,123.

Curis VS Emmaus

Emmaus is Curis's #1 rival. Emmaus is a Public company that was founded in Torrance, California in 2000. Like Curis, Emmaus also works within the Biotechnology field. Emmaus has 5 fewer employees vs. Curis.

Curis VS Kurome Therapeutics

Kurome Therapeutics is perceived as one of Curis's biggest rivals. Kurome Therapeutics was founded in 2019, and is headquartered in Cincinnati, Ohio. Like Curis, Kurome Therapeutics also operates in the Biotechnology sector. Kurome Therapeutics generates $10.3M less revenue vs. Curis.

Curis VS Kymera

Kymera is a top competitor of Curis. Kymera is a Public company that was founded in 2015 in Watertown, Massachusetts. Like Curis, Kymera also operates in the Biotechnology space. Compared to Curis, Kymera has 110 more employees.

Looking for similar companies to Curis?

Similar Companies

Biotechnology companies in Lexington

See 51 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 
Pharmaceuticals & Biotechnology companies in Lexington

See 67 companies 
Biotechnology companies in Massachusetts

See 1,343 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,717 companies 
Companies in Lexington with revenue in $5.0-25M range

See 3,422 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,620 companies 
Companies in Lexington with employees in 25-100 range

See 4,523 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Curis and Curis's Competitors

April 10, 2025Zacks
Kymera Therapeutics (KYMR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revision...
April 9, 2025Benzinga
NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., In...
April 10, 2025Yahoo
ACCESS Newswire · Evotec SE In This Article: HAMBURG, DE / ACCESS Newswire / April 10, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, IS...
April 9, 2025VC News Daily
BOSTON, MA, Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therape...
April 11, 2025BioSpace
Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include ...
April 9, 2025Benzinga
read more...
April 10, 2025Pharmabiz
Bristol Myers Squibb, announced that the US Food and Drug Administration (FDA) approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first─line tre...
April 9, 2025Bloomberg Law
A Federal Circuit panel appeared likely to reverse a district court's order blocking Sun Pharmaceutical Industries Ltd. from launching its new alopecia...
April 10, 2025Pharmaceutical Processing World
Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment a...
April 10, 2025Marketscreener
NEW YORK , April 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK). Shareholders...

Frequently Asked Questions about Curis

  1. Who are Curis's top competitors?

    Curis's top 3 competitors are Emmaus, Kurome Therapeutics, Kymera.

  2. Who is similar to Curis?

    Emmaus is the most similar to Curis. Kurome Therapeutics and Kymera are also similar to Curis.

  1. Are Curis and Emmaus competitors?

    Yes, Emmaus is one of Curis’s top competitors.